Q (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018

+Studies 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

QUALITY OF LIFE and CANNABIS/CANNABINOIDS
QUITTING/REDUCING CANNABIS USE*+ (See Also ADDICTION, WITHDRAWAL)
QUITTING/REDUCING OTHER DRUGS*+


QUALITY OF LIFE and CANNABIS/CANNABINOIDS
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health Related Quality of Life (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080871/?tool=pubmed
Is there a legitimate role for the therapeutic use of cannabinoids for symptom  management in chronic kidney disease? (full–2011)  http://www.jpsmjournal.com/article/S0885-3924%2810%2900979-6/fulltext
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to download–2011) http://www.dovepress.com/articles.php?article_id=7675
The afferent system and its role in lower urinary tract dysfunction (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21537194
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat  bone tumor pain model (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0304394010016228?via%3Dihub
Cannabis use amongst patients with inflammatory bowel disease (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21795981
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Profile of Psychoactive Substances Consumption in Workplace (abst in French & English–2011) https://www.journal-therapie.org/articles/therapie/abs/2011/02/th111929/th111929.html
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young  adulthood (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/217330
Rimonabant improves obesity but not the overall cardiovascular risk and quality of life;  results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the  Effectiveness in Daily practice and its USE) (full–2012)  http://fampra.oxfordjournals.org/content/29/5/521.full
The role of cannabinoids in prostate cancer: Basic science perspective and potential  clinical applications (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?tool=pubmed
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals  Managed Chronic Illness and Debility. (link to download–2012)  http://journals.sagepub.com/doi/full/10.1177/1049909112454215
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22095142
Therapeutic use of cannabis (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22479766
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the  world (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22632862
Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0091305712001438
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in  multiple sclerosis-related spasticity (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22509985
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of  cannabinoids (abst in English–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23011861  (abst in Spanish) https://www.neurologia.com/articulo/2012362
The use of cannabinoids in chronic pain (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736518/
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy  volunteers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243870/
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An  exploratory double-blind trial (abst–2014)  https://www.ncbi.nlm.nih.gov/pubmed/25237116
Cannabinoid mouth spray brought help to a severely spastic young man (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25158585 
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by  Parkinson’s Disease Patients in Colorado (full–2015)  http://www.hindawi.com/journals/ecam/2015/874849/
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on  Executive Function (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
The impact of drugs for multiple sclerosis on sleep (full–2016)  http://journals.sagepub.com/doi/full/10.1177/1352458516664034
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain:  A Prospective Open-label Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26889611
Pain in Extrapyramidal Neurodegenerative Diseases (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27623111
Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based  Therapies (full–2017)  http://www.ajmc.com/journals/supplement/2017/managed-care-considerations-in-chemotherapy-induced-nausea-andvomiting/overview-of-chemotherapy-induced-nausea-and-vomiting-and-evidence-based-therapies-article/
Associations between medical cannabis and prescription opioid use in chronic pain  patients: A preliminary cohort study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187795
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome  after Human Papillomavirus Vaccination (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4042
The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0376871617300881
Social correlates of health status, quality of life, and mood states in patients treated with  cannabidiol for epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
Cannabis use and the course and outcome of major depressive disorder: A population  based longitudinal study (abst–2017)  http://www.psy-journal.com/article/S0165-1781(16)31187-8/abstract
Cannabis use and mental health-related quality of life among individuals with depressive disorders (abst–2017) http://www.psy-journal.com/article/S0165-1781(15)30306-1/fulltext
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28454984
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based  investigation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28735833
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and  Related Conditions-III: Gender-specific profiles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28755613
The potential role of cannabinoids in epilepsy treatment. (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28845714
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Sativex in the management of multiple sclerosis-related spasticity: An overview of the  last decade of clinical evaluation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29055461
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28537982
Cognitive, physical, and mental health outcomes between long-term cannabis and
tobacco users (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304628?via%3Dihub
Preserving the independence of people living with multiple sclerosis towards the end of  life (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29087751
The effect of medical marijuana laws on the health and labor supply of older adults:  Evidence from the Health and Retirement Study (abst–2017)  http://www.nber.org/papers/w22688
Mechanisms and treatment of painful neuromas (full–2018)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity  and Improved Executive Function after 3 Months of Treatment (full–2018)  https://www.frontiersin.org/articles/10.3389/fphar.2017.00983/full


QUITTING/REDUCING CANNABIS USE
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users (full-2010)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461262/
Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3050879/?toolmcentrez
Adding Tobacco to Cannabis–Its Frequency and Likely Implications (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21454910
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in Cannabis-Dependent Adolescents (full–2012) http/ajp.psychiatryonline.org/article.aspx?articleID=1184217&resultClick=1
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3358737/
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335956/
Reduction of dependence to cannabinoids by GLT-1 activating property of the betalactam antibiotic (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/23253111
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23159379
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
A Randomized Double-blind, Placebo Controlled Trial of Venlafaxine-Extended Release for Co-occurring Cannabis Dependence and Depressive Disorders (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636166/
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3682150/
Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3641687/
Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3636012/
top
Pharmacokinetic and Pharmacodynamic Profile of Supratherapeutic Oral Doses of Δ9 – THC in Cannabis Users (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3691290/
Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: One year outcomes (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770780/
Cannabis use during a voluntary quit attempt: An analysis from ecological momentary assessment (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770798/
Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681844/
Self-Efficacy and Motivation to Quit Marijuana Use among Young Women (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913034/
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465638/
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2012.12050615
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23095052
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a reversal design: a case study (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23909004
Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals (abst–2013) https://link.springer.com/article/10.1007%2Fs00213-013-3342-z
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt (abst–2013) http/www.sciencedirect.com/science/article/pii/S030646031300172X
The effects of cannabis use expectancies on self-initiated cannabis cessation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23627879
Poor sleep quality as a risk factor for lapse following a cannabis quit attempt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23098380
Smoking mull: a grounded theory model on the dynamics of combined tobacco and  cannabis use among adult men (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24168742
Baclofen in the management of cannabis dependence syndrome (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3896138/
Systematic review of N-acetylcysteine in the treatment of addictions (full–2014) http/www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014005031244&lng=en&nrm=iso&tlng=en
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4118750/
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4009342/
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
top
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial (full–2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1812720
Open-label pilot study of quetiapine treatment for cannabis dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232231/
Achieving Cannabis Cessation – Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252394/
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during  controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation  with delta-9-tetrahydrocannabinol and -metabolites in serum (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25127704
Changes in cigarette and alcohol use during cannabis abstinence (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24613633
Physical activity and cannabis cessation (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24629045
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25459131
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015) http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545660/
Cannabis use history and characteristics of quit attempts: A comparison study of treatment-seeking and non-treatment-seeking cannabis users (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250402/
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
Vilazodone for cannabis dependence: A randomized, controlled pilot trial (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937726/
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with dependence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373963/
Effects of quitting cannabis on respiratory symptoms (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780250/
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633378/
Naltrexone Maintenance Decreases Cannabis Self Administration and Subjective Effects in Daily Cannabis Smokers (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569951/
Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747417/
Assessing the efficacy of MOTI-4 for reducing the use of cannabis among youth in the Netherlands: a randomized controlled trial (full–2015)  http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(15)00296-2/fulltext
Separate and combined effects of gabapentin and Δ9-THC in humans discriminating Δ9-
THC (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769128/
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co-use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25662704
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers (abst–2015)  http://www.drugandalcoholdependence.com/article/S0376-8716(15)00083-6/fulltext
top
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901778-0/abstract
The prospective effects of perceived and laboratory indices of distress tolerance on cannabis use following a self-guided quit attempt (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26727009
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
Digital Interventions for Problematic Cannabis Users in Non-Clinical Settings: Findings from a Systematic Review and Meta-Analysis (full–2016) http://www.karger.com/Article/FullText/445716
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male  Subjects After Abstinence From Cannabis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742341/
Attempts to Stop or Reduce Daily Cannabis Use: An Intensive Natural History Study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877269/
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial (full–2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
Black–White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net? (full–2016) http://www.mdpi.com/2076-328X/6/4/21/htm
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748964/
Hippocampal harms, protection and recovery following regular cannabis use (full–2016) http://www.nature.com/tp/journal/v6/n1/full/tp2015201a.html
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946059/
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878903/
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775311/
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861316/
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302052/
Topiramate and motivational enhancement therapy for cannabis use among youth: a  randomized placebo-controlled pilot study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26752416
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders  (abst–2016) http://journals.sagepub.com/doi/full/10.1177/1087054716640109
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by  Significant Changes in Blood Pressure and Heart Rate (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26761126
Environmental cues and attempts to change in daily cannabis users: An intensive  longitudinal study (abst–2016)  http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2900055-7/abstract
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27156221
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261670
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Exercise as an adjunctive treatment for cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314543
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27345297
Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484692
Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27424166
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27485997
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27521979
Oxytocin for the treatment of drug and alcohol use disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27603752
Bongs and baby boomers: Trends in cannabis use among older Australians (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27730759
Older marijuana users: Life stressors and perceived social support (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27776245
Cannabis and Young Users—A Brief Intervention to Reduce Their Consumption  (CANABIC): A Cluster Randomized Controlled Trial in Primary Care (full–2017) http://www.annfammed.org/content/15/2/131.long
The cannabis withdrawal syndrome: current insights (full–2017)  https://www.dovepress.com/the-cannabis-withdrawal-syndrome-current-insights-peer-reviewed-fulltext-article-SAR
Prevalence and correlates of treatment utilization among adults with cannabis use  disorder in the United States (full–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30228-4/fulltext
Social cognitive predictors of treatment outcome in cannabis dependence (full–2017) http://www.drugandalcoholdependence.com/articl
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in  adults (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30262-4/fulltext
Online self-help forums on cannabis: A content assessment (abst–2017) http://www.pec-journal.com/article/S0738-3991(17)30345-2/fulltext
Drug helplines and adult marijuana users: an assessment in Washington, Colorado,  Oregon, and Alaska (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28715253
“I feel like I’ve hit the bottom and have no idea what to do”: Supportive social networking on Reddit for individuals with a desire to quit cannabis use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28704167
Legalization of cannabis: Considerations for intervening with adolescent consumers  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28729196
Perceived barriers for cannabis cessation: Relations to cannabis use problems, withdrawal symptoms, and self-efficacy for quitting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28753466
Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
Sleep continuity, architecture and quality among treatment-seeking cannabis users: An  in-home, unattended polysomnographic study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28782982
CHRONIC Δ9-THC IN RHESUS MONKEYS: EFFECTS ON COGNITIVE PERFORMANCE AND DOPAMINE D2/D3 RECEPTOR AVAILABILITY (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29203575
Cannabis induced psychosis and subsequent psychiatric disorders (abst–2017)  http://www.asianjournalofpsychiatry.com/article/S1876-2018(17)30388-X/fulltext
Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent  Patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29105663
Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing  in dependent marijuana users after 28 days of abstinence (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4803-6
A scoping review and meta-analysis of psychosocial and pharmacological treatments for  cannabis and tobacco use among African Americans (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29199844
The efficacy of computerized interventions to reduce cannabis use: A systematic review  and meta-analysis (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304537?via%3Dihub
Is recovery from cannabis use problems different from alcohol and other drugs? Results  from a national probability-based sample of the United States adult population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29287223
Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29308437
Gene variants and educational attainment in cannabis use: mediating role of DNA  methylation (full–2018)  https://www.nature.com/articles/s41398-017-0087-1
Marijuana use among adults: Initiation, return to use, and continued use versus quitting  over a one-year follow-up period (full–2018)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30535-5/fulltext
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands (full–2018)  https://www.cambridge.org/core/journals/psychological-medicine/article/changes-in-cannabis-potency-and-firsttime-admissions-todrug-treatment-a-16year-study-in-the-netherlands/998695133558A106254C6291CD12FC06/core-reader
The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis  Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial (full–2018)  http://www.researchprotocols.org/2018/1/e30/
Negative affectivity as a mechanism underlying perceived distress tolerance and cannabis use problems, barriers to cessation, and self-efficacy for quitting among urban cannabis users (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304495?via%3Dihub
Mobile contingency management as an adjunctive treatment for co-morbid cannabis use  disorder and cigarette smoking (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304604?via%3Dihub
top


QUITTING/REDUCING OTHER DRUGS*+
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Achalasia, status post myotomy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2
Medical marijuana users in substance abuse treatment (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848643/?tool=pubmed
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2813317/?toolubmed
Randomized, controlled, double-blind trial of taranabant for smoking cessation (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20191360
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3227620/?toolubmed
Brain cannabinoid CB2 receptors modulate cocaine’s actions in mice (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3164946/
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01467.x/full
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in  California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
Health effects of using cannabis for therapeutic purposes: a gender analysis of users’  perspectives (abst in English, French & Spanish–2011)  http://www.tandfonline.com/doi/abs/10.3109/10826084.2010.537732?journalCode=isum20
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251 (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3697052/
top
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
The role of cannabinoids in prostate cancer: Basic science perspective and potential  clinical applications (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?tool=pubmed
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A  Randomized, Placebo-Controlled, Graded-Dose Trial (abst-2012)  http://www.sciencedirect.com/science/article/pii/S1526590012000193
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in  animals (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22807156
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22880540
A questionnaire survey of patients and carers of patients prescribed Sativex as an  unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings  (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/07/CBDcigarettes.pdf
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4058760/
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590996/
Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Anti-Withdrawal Effects in Morphine-Dependent Mice (full–2013) http/www.ncbi.nlm.nih.gov/pubmed/23303065
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742578/
Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717827/
The use of cannabinoids in chronic pain (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736518/
Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and  cannabis dependence: a pilot study (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641687/
Endocannabinoid system and drug addiction: new insights from mutant mice approaches (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23490550
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23510307
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT(1A) receptors in the dorsal raphe nucleus (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/22862835
Smoking mull: a grounded theory model on the dynamics of combined tobacco and  cannabis use among adult men (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24168742
Therapeutic benefits of cannabis: a patient survey (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3895301/
Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress induced relapse in rats (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu025.long
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents (full–2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4118750/
Can Cannabis be Considered a Substitute Medication for Alcohol? (full–2014) http://alcalc.oxfordjournals.org/content/early/2014/01/07/alcalc.agt182.full
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence (full–2014) http://www.jneurosci.org/content/34/8/2822.long
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161648/
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States,  1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress  Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other
Indications: A Retrospective Evaluation (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
Comparative effects of pulmonary and parenteral Δ9-tetrahydrocannabinol exposure on  extinction of opiate-induced conditioned aversion in rats (abst-2014)  http://www.ncbi.nlm.nih.gov/pubmed/25395060
Neuroinflammation as a possible link between cannabinoids and addiction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale  of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in
Long Term Behavior Therapy. (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Achalasia, status post myotomy (case report–undated)  http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015)
http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
Mull it over: cannabis vaporizers and harm reduction (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse (full–2015) http://www.nature.com/npp/journal/v40/n9/full/npp201562a.html
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604178/
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087/
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (full–2015) http://link.springer.com/article/10.1007%2Fs12630-015-0525-6
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of  Cannabinoid Receptor-1 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599364/
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in  rats (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits  potential of cannabinoids for crack-cocaine use (full–2015) http://www.ijdp.org/article/S0955-3959(15)00300-X/fulltext
Safety of oral dronabinol during opioid withdrawal in humans (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663169/
If at first you don’t succeed: characterization of smokers with late smoking abstinence
onset (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454339/
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (link to PDF-2015) https://www.semanticscholar.org/paper/Do-Medical-Marijuana-Laws-Reduce-Addiction-and-Dea-PowellLiccardo/de1ed809a834f74de4cb902b7546bc3dc17ef231
Profiles of medicinal cannabis patients attending compassion centers in rhode island  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to  explain high rates of co-use (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25662704
A safer alternative: Cannabis substitution as harm reduction (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25919477
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone  Maintenance Treatment: A French Prospective Study (abst–2015)  http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(15)00163-4/abstract
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder  in methadone-maintained outpatients (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26331953
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716(15)00250-1/abstract
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated  Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256
Tumor-Bearing Rats (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26720619
Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of  tobacco and marijuana in adults from 2003-2012 (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26036666
Synthetic cannabinoid withdrawal: A new demand on detoxification services (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25588420
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a  Humbug? (full–2016)  http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Impacts of Changing Marijuana Policies on Alcohol Use in the United States (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700545/
Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate  Withdrawal: A Review of the Preclinical Animal Literature (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923145/
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of  Administration and Their Association with Intention to Quit (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on  Executive Function (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid  CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel  Monkeys (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946059/
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861316/
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910823/
American Attitudes toward Substance Use in the United States (click “Cancel” for link to download–2016)  http://www.apnorc.org/projects/Pages/american-attitudes-toward-substance-use-in-the-united-states.aspx
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26971034
Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation  medications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26806777
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through  cannabinoid CB1 receptor in rats (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26864774
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation  Products (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27106177
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in  Wistar rats (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26833888
top
Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Index of Cognitive Disruption during Nicotine Withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453054

The association between cannabis use and motivation and intentions to quit tobacco within a sample of Australian socioeconomically disadvantaged smokers (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27923866
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally  Injured Drivers (abst–2016)  http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303426?journalCode=ajph
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain:  A Prospective Open-label Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26889611
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016)  http://www.jpain.org/article/S1526-5900(16)00567-8/fulltext
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)  http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Two steps forward, one step back: current harm reduction policy and politics in the  United States (full–2017)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0157-y
Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive Behavioral Treatment for PTSD and Substance Use Disorders (full–2017)  http://www.mdpi.com/2077-0383/6/2/14/htm
Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine  Withdrawal Symptoms in Adult Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486147/
Cannabis as a substitute for prescription drugs – a cross-sectional study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive  Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive Behavioral Treatment for PTSD and Substance Use Disorders (full–2017)  http://www.mdpi.com/2077-0383/6/2/14/htm
Alterations in Rat Accumbens Endocannabinoid and GABA Content during Fentanyl  Treatment: The Role of Ghrelin (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713452/
Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187795
Medical Cannabis in Residential Transition or Addiction Programs: A Review of Clinical  and Cost-Effectiveness and Guidelines [Internet] (full–2017)  https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0097462/
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360  suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance  and dependence (link to download–2017)  http://molpharm.aspetjournals.org/content/early/2017/11/30/mol.117.109355.long
Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational  intervention (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31203-3/fulltext
Medical cannabis access, use, and substitution for prescription opioids and other  substances: A survey of authorized medical cannabis patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189912
Chronic Pain Patients’ Perspectives of Medical Cannabis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28328576
Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28399488
Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28431292
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
Prevalence, correlates, and trends in tobacco use and cessation among current, former,  and never adult marijuana users with a history of tobacco use, 2005-2014 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28525833
The cannabinoid system and pain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730285X
Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and  craving among patients of addiction clinics in Kazakhstan: A prospective case-control  study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28631421
CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with  affective opioid withdrawal in rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28714716
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based  investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28735833
Post-High School Changes in Tobacco and Cannabis Use in the United States (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28742412
Demographic and clinical characteristics of treatment seeking women with full and  subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28793355
Topical Medical Cannabis (TMC): A new treatment for wound pain-Three cases of  Pyoderma Gangrenosum (abst–2017) http://www.jpsmjournal.com/article/S0885-3924(17)30351-2/fulltext
Preferences for Medical Marijuana over Prescription Medications Among Persons Living  with Chronic Conditions: Alternative, Complementary, and Tapering Uses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28945457
THC inhibits the expression of ethanol-induced locomotor sensitization in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29084627
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2  agonists (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390816305639
Opioid-sparing Effect of Cannabinoids: A Systematic Review and Meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28327548
Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and  alcohol-induced accumbal dopaminergic signaling (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817305075?via%3Dihub
Pooled analysis of three randomized, double-blind, placebo controlled trials with  rimonabant for smoking cessation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28429843
A scoping review and meta-analysis of psychosocial and pharmacological treatments for  cannabis and tobacco use among African Americans (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29199844
Associations between medical cannabis and other drug use among unstably housed  women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29227883
Is recovery from cannabis use problems different from alcohol and other drugs? Results  from a national probability-based sample of the United States adult population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29287223
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881117699616
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity  and Improved Executive Function after 3 Months of Treatment (full–2018)  https://www.frontiersin.org/articles/10.3389/fphar.2017.00983/full
Mobile contingency management as an adjunctive treatment for co-morbid cannabis use  disorder and cigarette smoking (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304604?via%3Dihub
Formal and Informal Control of Cannabis: Regular Users’ Experience (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29336651
Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338578


Advertisements